针对氧化应激作为心血管疾病的预防和治疗方法
Qian Yan1, Shasha Liu2, Yang Sun1
1Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, College of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Journal of translational medicine
|August 2, 2023
概括
草本单体通过增强抗氧化系统和减少活性氧物种 (ROS) 来对抗心血管疾病 (CVD) 中的氧化应激. 这些化合物为保护心脏健康免受氧化损伤提供了一个有希望的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管疾病 (CVD) 是全球死亡的主要原因之一.
- 氧化应激 (OS) 是心血管疾病发展和进展的关键因素.
- 平衡活性氧物种 (ROS) 和抗氧化剂对于心脏健康至关重要.
研究的目的:
- 审查OS的机制及其与心血管疾病的联系.
- 探索草本单体作为抗氧化剂对心血管疾病的治疗潜力.
- 为了检查草本单体对心脏信号通路的心脏保护作用.
主要方法:
- 关于氧化应激机制的文献综述.
- 分析OS在心血管疾病发病过程中的作用.
- 对草本单体的抗氧化和心脏保护作用的研究的评估.
主要成果:
- 草本单体可以通过增强内源性抗氧化剂系统来减轻OS.
- 这些化合物降低ROS水平,从而保护心脏功能.
- 草本单体通过调节信号通路显示出显著的心脏保护作用.
结论:
- 草本单体代表了一种有希望的治疗途径,用于控制心血管疾病中的氧化应激.
- 用草本单体向OS可以帮助保持心脏功能并减少疾病的进展.
- 对特定的草本单体及其机制进行进一步的研究是必要的,以获得临床应用.
相关概念视频
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Radical Autoxidation
2.2K
The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.2K
Psychoneuroimmunology: Cardiovascular Disease
52
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
52
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12


